fda warning letter glp-1 solution september 2025 The U.S. Food and Drug Administration (FDA) has issued a to Novo Nordisk over its alleged failure to report adverse side effects, including death, in patients who took its medications GLP-1 RA prescription trends: January

Genome-wide profiling of piggybac transposon insertion mutants reveals loss of the F 1 F 0 ATPase complex causes fluconazole resistance in Candida glabrata

Measure baseline renal function, adjust dosing or intervals accordingly, and plan washout periods based on the slowest eliminator in your cohort, not the average

Absorption across the gut epithelium, first-pass liver metabolism, and systemic distribution are all separate steps that determine whether an orally administered compound reaches target tissues at meaningful concentrations

That's a fancy way of saying it's a chain of 15 amino acids, originally derived from a protein found in human gastric juice

The enzymes which carry out the process of reduction also require a co-enzyme NADPH (nicotinamide adenine dinucleotide phosphate hydrogenase) [6]